Healthcare industry

Article - 23/04/2019

How can care infrastructures benefit from digitization?

The pilot project NeCTra (Networking - Care - Transparency) investigates how care processes within an urban social environment can be improved by using digital technologies. The goal is to bring together all partners and institutions in real time so that people in need of care and those seeking advice receive appropriate support more quickly.

Article - 30/10/2018

Eucor – bringing the European Campus to life

Enrolling at one university and being able to use the services of a total of five universities is unique in the European Research Area. A model project called Eucor - The European Campus offers students and young scientists this opportunity at universities in the Germany-France-Switzerland border triangle, which simultaneously acts as a borderless academic area for the sciences.

Article - 23/03/2017

CeMIT – professional innovation management for the medical device sector

With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…

Article - 20/03/2017

Expansion of the de.NBI, the German Network for Bioinformatics Infrastructure

The German Network for Bioinformatics Infrastructure, de.NBI for short, is a successful model for infrastructures in the life sciences and biomedicine that is currently being expanded. The network, which was established in 2015, will benefit from more hardware, more staff, more projects and its own cloud. It has also joined the European ELIXIR network.

Article - 26/09/2016

TuCADD: Coaching for early drug candidates

The University of Tübingen is optimising its drug development pipeline. The TuCADD consortium provides professional help to people who want to take potential drug candidates to clinical application. The coaching involves assistance with the entire phase I drug development phase from industry experts.

Article - 02/02/2016

EU consortium to speed up innovations in the healthcare sector

EIT Health is a large-scale European project launched in December 2014 that aims to help people in Europe to live a healthier life and stay active as they grow older. The consortium brings together 140 leading companies and institutions from 14 European countries and has a total budget of two billion euros. It is one of the largest networks worldwide in the healthcare sector.

Press release - 22/07/2013

BIOPRO Baden-Württemberg's international relations bring Heidelberg-based Medicyte GmbH in contact with new distribution partner

BIOPRO Baden-Württembergs business development activities have led to the establishment of a new distribution partnership between Heidelberg-based Medicyte GmbH and Dutch Westburg BV. When BIOPRO searches for international partners for Baden-Württemberg companies the state agency often makes use of its international network partners and in this case BIOPROs contact with the Netherlands Business Support Office Stuttgart NBSO brought the desired…

Article - 15/04/2013

Price pressure requires new product developments – the "Bioactive Plant Foods" network

The Bioactive Plant Foods network which is coordinated by the Steinbeis-Europa-Zentrum in Stuttgart is focused on developing innovative products that have a positive effect on human health and placing them on the market. Research resolves around the health-promoting effect of amaranth a short-lived plant with catkin-like cymes of densely packed red flowers. More than 20 partners from industry science and marketing have been working together since…

Article - 16/04/2012

Pharma 2.0: towards paperless production

Before electronic solutions existed lorries were needed to ship new drug applications which often comprised 500000 or so pages. Thanks to IT this is no longer necessary. IT-based procedures and solutions are playing an increasing role in all areas of the pharmaceutical industry. Markus Roemer CEO of Ravensburg-based comes compliance services supports companies in implementing legal guidelines in this area. In the following interview Roemer talks…

Article - 09/01/2012

Parkinson’s disease – a fatal cycle of falling and rising activity in the basal ganglia

As the disease progresses Parkinsons patients find it increasingly difficult to voluntarily control body movements. The disease is associated with oscillations of electrical activity in specific brain areas known as basal ganglia. Dr. Arvind Kumar and his colleagues at the Bernstein Center Freiburg have used neuronal network simulations to develop a model to explain these rhythmic oscillations.

Press release - 16/06/2010

Network for the promotion of bio-active plant ingredients

The Steinbeis-Europa-Zentrum receives funding to build a network for "Bio-active plant ingredients” in Baden-Wuerttemberg from the "Central Innovation programme SME - ZIM" under the funding module NEMO of the Federal Ministry of Economics and Technology. BIOPRO Baden-Wuerttemberg GmbH supports the network as one of the partners.

The second Science to Market Conference took place in Hannover, Germany, on October 6 – 7, 2009. The aim of the conference was the promotion of cooperation between academia and industry in the area of pharmaceutical biotechnology.

Press release - 09/10/2009

BIOTECHNICA 2009 - turning ideas into value

BIOTECHNICA 2009 which took place in Hanover Germany from 6th to 8th October 2009 featured the seminal motto Turning ideas into value. The exhibition programme was rounded off by numerous talks and plenary discussions held at the joint Baden-Württemberg booth.

“In order to fully understand an organism, it is necessary to consider it as a whole,” said Dr. Uwe Schulte, biochemist and CEO of Logopharm GmbH in Freiburg. A growing number of scientists hold the same view, and there is a growing inclination to research the big picture. This is reflected in the continuously increasing number of projects looking into systems biology research.